Nektar Therapeutics
NKTR
#5687
Rank
โ‚ฌ0.99 B
Marketcap
48,87ย โ‚ฌ
Share price
-1.37%
Change (1 day)
238.13%
Change (1 year)

Nektar Therapeutics (NKTR) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ0.23 Billion

According to Nektar Therapeutics 's latest financial reports the company has โ‚ฌ0.23 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Nektar Therapeutics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.24 B-10.7%
2023-12-31โ‚ฌ0.27 B-41.66%
2022-12-31โ‚ฌ0.47 B-27.36%
2021-12-31โ‚ฌ0.64 B-24.93%
2020-12-31โ‚ฌ0.86 B-27%
2019-12-31โ‚ฌ1.18 B1.32%
2018-12-31โ‚ฌ1.16 B372.95%
2017-12-31โ‚ฌ0.24 B-33.28%
2016-12-31โ‚ฌ0.36 B30.92%
2015-12-31โ‚ฌ0.28 B44.49%
2014-12-31โ‚ฌ0.19 B13.93%
2013-12-31โ‚ฌ0.17 B-18.1%
2012-12-31โ‚ฌ0.20 B12.84%
2011-12-31โ‚ฌ0.18 B-21.81%
2010-12-31โ‚ฌ0.23 B-14.11%
2009-12-31โ‚ฌ0.27 B2.01%
2008-12-31โ‚ฌ0.27 B-17.94%
2007-12-31โ‚ฌ0.33 B-4.96%
2006-12-31โ‚ฌ0.34 B-13.53%
2005-12-31โ‚ฌ0.40 B30.23%
2004-12-31โ‚ฌ0.30 B35.9%
2003-12-31โ‚ฌ0.22 B-19.23%
2002-12-31โ‚ฌ0.28 B-27.88%
2001-12-31โ‚ฌ0.38 B-24.24%
2000-12-31โ‚ฌ0.51 B274.78%
1999-12-31โ‚ฌ0.13 B96.66%
1998-12-31โ‚ฌ69.82 M-17.28%
1997-12-31โ‚ฌ84.41 M438.56%
1996-12-31โ‚ฌ15.67 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
โ‚ฌ8.11 B 3,395.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ12.86 B 5,445.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ15.64 B 6,640.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
โ‚ฌ30.62 M-86.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ7.02 B 2,928.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
โ‚ฌ1.48 B 538.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚ฌ0.95 B 311.21%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
โ‚ฌ15.94 B 6,769.52%๐Ÿ‡บ๐Ÿ‡ธ USA